Fifth Third Bancorp
RGNX icon

Fifth Third Bancorp’s Regenxbio RGNX Stock Holding History

Fifth Third Bancorp’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-810
Closed -$6.26K – 2600
2024
Q4 		$6.26K Buy
810
+19
+2% +$178 ﹤0.01% 2109
2024
Q3 		$8.3K Buy
791
+501
+173% +$6.11K ﹤0.01% 2061
2024
Q2 		$3.39K Sell
290
-327
-53% -$5.09K ﹤0.01% 2196
2024
Q1 		$13K Buy
617
+531
+617% +$9.45K ﹤0.01% 1796
2023
Q4 		$1.54K Sell
86
-19
-18% -$335 ﹤0.01% 2370
2023
Q3 		$1.73K Sell
105
-37
-26% -$671 ﹤0.01% 2403
2023
Q2 		$2.84K Buy
142
+76
+115% +$1.46K ﹤0.01% 2357
2023
Q1 		$1.25K Buy
66
+35
+113% +$774 ﹤0.01% 2614
2022
Q4 		$703 Buy
+31
New +$701 ﹤0.01% 2574
2022
Q2 		– Sell
-155
Closed -$5K – 2767
2022
Q1 		$5K Sell
155
-70
-31% -$1.94K ﹤0.01% 2325
2021
Q4 		$7K Buy
225
+167
+288% +$5.69K ﹤0.01% 2237
2021
Q3 		$2K Buy
+58
New +$2.09K ﹤0.01% 2494

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Fifth Third Bancorp's RGNX Position: Q1 2025 in Review

Fifth Third Bancorp sold out of Regenxbio (RGNX) in Q1 2025, closing a stake of 810 shares — an estimated $6.26K sold.

Fifth Third Bancorp first reported a position in RGNX in Q3 2021 and held it in 12 quarters. The position peaked at $13K in Q1 2024. 164 funds tracked by Wall St. Rank hold RGNX as of Q1 2025.

  • Fifth Third Bancorp reported no remaining Regenxbio position as of Q1 2025 after selling out during the quarter.
  • Fifth Third Bancorp sold 810 Regenxbio shares in Q1 2025, an estimated $6.26K.
  • Fifth Third Bancorp first reported a position in Regenxbio in Q3 2021 and held it in 12 quarters.
  • Fifth Third Bancorp's Regenxbio position peaked at $13K in Q1 2024.
  • 164 funds tracked by Wall St. Rank held Regenxbio as of Q1 2025.

Based on Fifth Third Bancorp's 13F filing for Q1 2025, filed 15 Apr 2025.